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Currently, numerous liver injury cases related to a famous Chinese herb- Polygonum
Multiflorum (Heshouwu in Chinese) have attracted great attention in many countries. Our
previous work showed that Heshouwu-induced hepatotoxicity belonged to idiosyncratic
drug-induced liver injury (IDILI). Unfortunately, the components and mechanisms
attributed to IDILI of Heshouwu are difficult to determine and thus remain unknown.
Attempts to explore puzzles, we prepared the chloroform (CH)-, ethyl acetate (EA)-,
and residue (RE) extracts of Heshouwu to investigate IDILI constituents and underlying
mechanisms,using biochemistry, histopathology, and metabolomics examinations. The
results showed that co-treatment with non-toxic dose of lipopolysaccharide (LPS) and
EA extract could result in evident liver injury, indicated by the significant elevation of
plasma alanine aminotransferase and aspartate aminotransferase activities, as well as
obvious liver histologic damage; whereas other two separated fractions, CH and RE
extracts, failed to induce observable liver injury. Furthermore, 21 potential metabolomic
biomarkers that differentially expressed in LPS/EA group compared with other groups
without liver injury were identified by untargeted metabolomics, mainly involved two
pathways: tricarboxylic acid cycle and sphingolipid metabolism. This work illustrated
EA extract had close association with the idiosyncratic hepatotoxicity of Heshouwu and
provided a metabolomic insight into IDILI of different extracts from Heshouwu.
Keywords: metabolomics, Polygonum multiflorum, idiosyncratic liver injury, stilbenes, pathway analysis
INTRODUCTION
The rising popularity of herbal medicines has promoted its use worldwide with a deep belief that
herbs are safe because they are “natural” (Cheung, 2011; Stickel and Shouval, 2015). However,
recent reports about herbs related hepatotoxicity from the literature are increasing (Navarro et al.,
2014; Vuppalanchi et al., 2015). The Polygonum multiflorum (Heshouwu in Chinese), a popular
traditional Chinese medicine, is widely used in hair-blacking and liver-and kidney-nourishing,
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even as dietary supplements. Nevertheless, numerous cases of
Heshouwu and its preparations induced significant liver injury
have emerged in recent years (But et al., 1996; Park et al., 2001;
Mazzanti et al., 2004; Panis et al., 2005; Cardenas et al., 2006;
Laird et al., 2008; Jung et al., 2011; Dong et al., 2014; Ma et al.,
2014). The risks of Heshouwu-containing drugs have attracted
much attention in many countries, and the regulations of those
products had been strengthened by the Medicines and Healthcare
Products Regulatory Agency (MHRA) of the United Kingdom
and the China Food and Drug Administration (CFDA) in 2006
and 2013, respectively.
Unfortunately, the hepatotoxic chemicals and mechanisms
attributed to Heshouwu induced liver injury remain unknown. It
has been speculated that the toxicity may be related to stilbenes
(Wu et al., 2012) or anthraquinones (Westendorf, 1993; Yu
et al., 2011; Ma et al., 2015), which are main constituents of
Heshouwu, but this hypothesis is in dispute and has not been
proven. Although predictable liver toxicities are often discovered
in preclinical and clinical testing for drugs, such testing does not
apply to herbs because of their complex features (Willett et al.,
2004). Furthermore, hepatotoxicity associated with Heshouwu is
also extremely difficult to recognize or assess as it is idiosyncratic.
A critical need exists to predict idiosyncratic drug-induced liver
injury (IDILI) of Heshouwu and understand the mechanisms
behind it. Currently, diagnostic methods of drug-induced liver
injury (DILI), measuring levels of aspartate aminotransferase
(AST) and alanine aminotransferase (ALT) etc. in blood samples,
have been considered as the current “gold standard” for initial
diagnosis and surveillance (Wang X. et al., 2012). However,
these markers only offer a destination indicator and may
lack sufficient sensitivity. Metabolomics, a powerful technology,
could systematically assess metabolic profiles in easily accessible
biofluids and biomarker discovery. Because this is a noninvasive
technique, many diagnostic biomarkers and pathways of the
organism can be tracked prior to toxicant exposure or during
disease. Metabolomics has been successfully employed to identify
specific biomarkers of toxicant exposure, which eventually could
be used for early warnings of liver injury in clinic (Weiss and Kim,
2011; Xue et al., 2014; Rofiee et al., 2015).
In the light of the characteristic advantages of metabolomics,
we hypothesized that metabolomics could detect the idiosyncratic
hepatotoxicity biomarkers after exposure to constituents
in Heshouwu. Therefore, in this study, UHPLC-MS-based
metabolic approach was performed to investigate toxic
components related to IDILI of Heshouwu. Moreover, to dig
the underlying mechanism, specific biomarkers and pathways
were discovered by pattern recognition and enriched pathways
analysis.
MATERIALS AND METHODS
Chemicals, Reagents, and Materials
Acetonitrile (HPLC grade) was purchased from Merck
(Darmstadt, Germany); Formic acid and methanol were
HPLC grade, and obtained from Fisher Chemicals (Pittsburg, PA,
USA); water was purified by a Millipore’s ultrapure water system
(Millipore, Bedford, MA, USA). Lipopolysaccharide (LPS)
and sodium pentobarbital (Cat#P3761) were purchased from
Sigma Chemical Company. LPS Derived from Escherichia coli,
055:B5 (Lot#113M4068V). Assays kits for the detection of serum
alanine ALT and AST were purchased from Jiancheng Biological
Technology, Co., Ltd (Nanjing, China). All other reagents and
solvents were of the highest grade commercially available. The
dry roots of P. multiflorum Thunb. (BN.13101701, Hubei, China)
were purchased from Beijing Lüye Pharmaceutical Company and
voucher specimen was deposited in China Military Institute of
Chinese Medicine. P. multiflorum was verified to have met the
standards specified by Chinese Pharmacopoeia.
Sample Preparation for Different
Extracts of P. multiflorum
The dried raw Heshouwu extracts were prepared through
extraction eight times with a 50% ethanol-water solution by
virtue of the cold soaking method, which was repeated two
times for 48 h each time. The extracted liquid was mixed,
filtered, and then concentrated under reduced pressure and
dried under vacuum. Then the crude extract was diluted with
deionized water to a suitable concentration. The diluted extract
was then extracted with an equal volume of chloroform five
times and subjected to vacuum drying to obtain the chloroform
extract (CH). The ethyl acetate extract (EA) was obtained
by further extracting the remaining aqueous fraction with an
equal volume of ethyl acetate nine times. The remaining ethyl
acetate-extracted aqueous portion was evaporated to obtain the
Heshouwu residue (RE).
Animals, Administration, and Sample
Collection
Male Sprague−Dawley rats (180−250 g) were obtained from
the Laboratory Animal Center of the Academy of Military
Medical Sciences (License No. SYXK 2007- 004, Beijing, China).
Animals received food and water ad libitum under standard
husbandry conditions (25 ± 2◦C temperature, 50−60% relative
humidity and 12 h photoperiod) for 1 week of acclimatization. All
procedures on animals and their care complied with the Guiding
Principles for the Care and Use of Laboratory Animals of China
and Institutional Animal Care and Use Committee of 302 hospital
of PLA. The assessment of idiosyncratic hepatotoxicity was based
on our previously reported rat model, which was modified
from the literature. Briefly, the animals were intragastrically
administered different extracts of Heshouwu or an equivalent
volume of normal saline, followed by tail vein injection of
LPS (2.8 mg/kg, Sigma) or normal saline 3 h later. At 7 h
after the injection of LPS, rats were anesthetized with sodium
pentobarbital (50 mg/kg, i.p.). Blood was collected from the
inferior vena cava by the syringe containing sodium citrate
(0.38% final concentration) after a midline abdominal incision,
and the liver was removed. The isolated livers were utilized for
histopathological examination and theplasma samples separated
from the collected blood were applied for analysis of AST and
ALT activities.
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Plasma ALT and AST Activities and
Histopathological Assessment
After centrifugation (3,000 rpm, 10 min), plasma ALT and
AST activities were determined according to the procedure
of microplate assay kits. The left lateral liver lobes obtained
were fixed in 10% neutral buffered formalin for at least 72 h
before being processed for histologic analysis. Paraffin-embedded
sections were cut at a 4 µm thickness and stained with
hematoxylin and eosin for microscopic examination.
Sample Preparation for Metabolomics
Two hundred microliter thawed plasma samples and 600 µL
methanol were transferred to a 1.5 mL polypropylene tube
andcentrifuged at 10,000 rpm for 10 min at 4◦C. Supernatants
were collected to filter through a syringe filter (0.22 µm).
Chromatography and Mass
Spectrometry Condition
Chromatographic analysis was performed in an Agilent
6550 iFunnel Q-TOF LC/MS (Agilent Technologies, USA).
A ZORBOX RRHD C18 analytical column (100 mm × 2.1 mm.,
1.7 µm, Agilent Technologies, USA), maintained at 30◦C, was
used for chromatographic separation. The sample sequence
was random and 4 µL aliquot of each sample was injected
into the column. The optimal mobile phase consisted of
solvent A (0.1% formic acid in water) and solvent B (0.1%
formic acid in acetonitrile). The flow rate was 0.3 mL/min
with a linear gradient used was as follows: 0−1 min, 5% B;
1−9 min, 5 to 40% B; 9−19 min, 40 to 90% B; 19−21 min,
90 to 100% B; 21−25 min, 100% B. A 5-min post run time
was inserted before the next sample. To ensure the stability
and repeatability of the systems, a quality control (QC)
sample was employed to optimize the condition of UHPLC-Q-
TOF/MS, as it included majority of the whole plasma samples’
information. All the samples were holded at 4◦C during the
experiment.
The mass spectrometry was performed by the Agilent 6550
Q-TOF/MS with an electrospray ionization source (ESI) in
both positive and negative mode. The optimal conditions of
analysis were set as follows: dry gas flow rate was 11 L/min;
dry gas temperature was set at 200◦C in negative ionization
mode and 225◦C in positive ionization mode. Sheath gas
flow rate 11 L/min and sheath gas temperature was 350◦C.
Electrospray capillary voltage was 3.0 kV in negative mode
and 4.0 kV in positive mode. Nozzle voltage was 500 V in
negative mode and the same as in positive mode. Nebulizer
pressure was set to 35 psig (negative) and 45 psig (positive). MS
data were gathered in the full scan mode from m/z 80−1200
with a scan rate of 1 spectra/s. For internal mass calibration
during the MS analysis, reference masses 112.9856 (TFANH4,
[C2H4O2NF3-NH4]-) and 1033.9881 (TFANH4+HP-0921,
[C20H22O8N4P3F27-NH4]-) were used in negative mode,
and 121.0509 (Purine, [C5H4N4+H]+) and 922.0098 (HP-
0921, [C18H18O6N3P3F24+H]+) were used in positive
mode.
Data Processing and Pattern
Recognition Analysis
All data were pre-processed with Profinder. For molecular feature
extraction, up to 2000 compounds with peak height above 300
counts were extracted, the binning and alignment settings were
“RT window” = 0.3 min and “mass window” = 35 ppm. Then
the data was introduced into the SIMCA-P 13.0 version, which
was used for multivariate statistical analyses including principal
component analysis (PCA) and orthogonal partial least squares
discriminant analysis (OPLS-DA) (Zhang et al., 2016).
The variable influence on the projection (VIP) parameter
was applied to choose variables that have the most significant
contribution in discriminating between metabolomic profiles
of experimental animal groups in an OPLS-DA model. Only
variables with VIP values >1 and | p (corr)| ≥ 0.5 were selected
and used for further data analysis.
Biomarker Identification and Metabolic
Pathway Analysis
Compounds were selected as potential biomarkers with
significant changes among groups (p-value < 0.05 and folder
change > 1.5). They were identified by Agilent MassHunter
PCDL Manager software, with KEGG1 database. To further
identify the metabolic pathways, the pathway analysis of
potential biomarkers was executed with MetaboAnalyst 3.02 on
the basis of the te pathway library of Rattus norvegicus (rat).
When the test p value is less than 0.05, statistical differences are
considered significant.
RESULTS
Chemical Compositions Determination
of the Different Extracts of P. multiflorum
The chemical compositions of different extracts of Heshouwu
were determined by UHPLC approach, which was showed in
Supplementary Material. The results indicated that there were
a roughly separation within the CH, EA, and RE extracts.
The EA extract contained mostly stilbenes (TSG) and trace
anthraquinone glycoside (emodin-8-O- glucoside). The CH
extract contained only anthraquinones (mostly emodin-8-O-
glucoside and emodin), and the RE extract contained neither
anthraquinones nor stilbenes. Supplementary Figure S1 shows
the representative UHPLC chromatograms of mixed standards
(Supplementary Figure S1A) and the different Heshouwu extracts
(Supplementary Figures S1B–D).
Liver Functional and Histologic Changes
of Different Extracts of P. multiflorum
Treatment of rats with isolated extract fractions (EA, CH, and RE)
alone did not induce significant increases in plasma ALT and AST
activities compared with normal group (P > 0.05). Likewise, no
increase in ALT and AST activities were evident with the dose
1www.genome.jp/kegg/
2http://www.metaboanalyst.ca/
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FIGURE 1 | (A) Representative microphotographs of liver sections isolated from rats. HE staining (×200). (B,C) Influence of co-treatment with lipopolysaccharide
(LPS) and different extracts of Polygonum multiflorum on plasma aminotransferase (ALT) and aspartate aminotransferase (AST) activities. For LPS-treated groups,
“−” and “+” represent intravenous administration of saline and 2.8 mg·kg−1 of LPS, respectively, and for drug-treated groups, “−”,“chloroform, CH”, “ethyl acetate,
EA”, and “residue, RE” represent intragastric administration of saline and “CH”, “EA”, and “RE”, respectively. Saline-treated group served as a control group and
LPS-treated group served as a model group. n = 10, x ± s. ∗P < 0.05 vs. control group; #P < 0.05 vs. model group.
of LPS used in the study (P > 0.05). However, ALT and AST
activities were remarkably increased in rats cotreated with LPS
and EA extract. In contrast, administration of CH or RE extract
to LPS-treated rats did not result in markedly increased plasma
ALT and AST compared with both the normal and LPS control
groups (Figures 1B,C).
Livers from saline-treated (control), EA-treated, CH-treated
and RE-treated rats had no or minimal histopthological changes.
Treatment with LPS (2.8 mg/kg, i.v.) alone caused slight
infiltration of inflammatory cells in portal area but no evident
hepatocytes injury. Co-treatment with LPS (2.8 mg/kg, i.v.)
and EA caused hepatocyte focal necrosis, loss of central vein
intima and a large number of inflammatory cell infiltration
in portal areas that had high plasma ALT and AST activities
(Figure 1A). These data suggested that the EA extract, but
not the CH or RE extract, probably plays the major role
in the pathogenesis of the idiosyncratic hepatotoxicity of
Heshouwu.
Multivariate Statistical Analysis of the
Metabolomics Data
Using UHPLC system, global metabolic profiles in both negative
and positive ion modes were analyzed. For better visualizing
the subtle differences among these complex data sets, multiple
pattern recognition methods were applied to differentiate
the phenotype from plasma metabonome of rats. Firstly, an
unsupervised PCA statistical method was employed to study the
metabolic differences. The score plots of PCA analysis derived
from data of ESI- mode and ESI+ mode are shown in Figure 2
and Supplementary Figure S2, respectively. Each point represents
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FIGURE 2 | Principal component analysis (PCA) score plots of different extracts of P. multiflorum by UHPLC-MS in negative electrospray ionization
source (ESI) mode.
an individual sample in the PCA scores. The PCA results
are displayed as score plots demonstrating the scatter of the
samples, which suggest compositionally different metabolomes
when dispersed andsimilar metabolomic compositions when
clustered together. The different plasma samples could be divided
into different blocks by the PCA scores plot, indicating that
the metabolic profiles have changed. The QC samples clustered
closely in both ESI- and ESI+ score plots, indicating the stability
of the LC/MS system throughout the whole analysis. An obvious
separation trend can be observed among the control, LPS,
LPS/CH, LPS/EA, and LPS/RE groups in both PCA model,
demenstrating there was a considerable metabolite difference
among the five groups. Besides, it should be noted that there is a
small overlapping among the control, LPS, LPS/CH, and LPS/RE
groups, whereas LPS/EA group is far away from the remaining
four groups,which indicate that changed metabolic pattern
resulted from EA-induced liver injury may be significantly
different from others.
To further investigate the metabolic changes among different
groups, the clustering heatmaps were constructed based on the
differential metabolites of importance, which were extracted with
PCA analysis in negative ESI mode and in positive mode. As
shown in Figure 3 and Supplementary Figure S3, we found that
that this model was capable of distinguishing LPS/EA group from
control, LPS, LPS/CH, and LPS/RE groups.
To highlight the metabolite differentials among LPS/CH,
LPS/EA, and LPS/RE groups respectively, the supervised method,
OPLS-DA, was used to classifiy or discriminate analyses, for its
calculation yielded a significantly distinct degree of biological
variation. The result of OPLS-DA model derived from data
of ESI− analysis is displayed in Figures 4A−F, respectively,
suggesting that the metabolic profiles have changed. The analyst
of OPLS-DA model using the data from the LPS/CH and LPS/EA
groups are showed in Figure 4A. As Figure 4A reports, the
score plot of OPLS-DA model was reliable. The LPS/EA group
can be separated from LPS/CH group very clearly. The LPS/EA
indicated good predictive ability with a R2X (cum) of 0.586, R2Y
(cum) of 0.990, and Q2 (cum) of 0.661. Likewise, the OPLS-
DA model was constructed based on the LPS/EA and LPS/RE
data (Figure 4C). The LPS/EA group can be separated from
LPS/RE group clearly. The R2X (cum), R2Y (cum), and Q2
(cum)were 0.631, 0.996, and 0.503, respectively. In addition, clear
separation was observed among LPS/EA, LPS/CH and LPS/RE
groups in the score plot. The LPS/EA group was clustered
together and relatively far from other two groups, which were
aggregated in the same region. It also indicated the trend of EA-
induced liver injury in LPS-treated rats (Figure 4E). The values of
R2X(cum), R2Y(cum), and Q2Y(cum) as 0.606, 0.812, and 0.502,
respectively. The data analysis of ESI+mode was also conducted
and are shown in Supplementary Figure S4. All the parameters of
PCA and OPLS-DA model are listed in Supplementary Table S1.
Potential Biomarker Selection,
Discovery, and Explanation
Potential markers were selected in accordance with their
contribution to the correlation and variation within the data
set, which were extracted from S-plots constructed following the
OPLS analysis. In the S-plots, the variables farther away from
the origin contribute significantly and are responsible for the
separation between aforementioned groups and may therefore be
viewed as potential biomarkers. In general, variables with a VIP
value >1 were pre-selected as potential biomarkers. To decrease
the risk of false positives in a choice of potential biomarkers,
variables with | p (corr)| ≥ 0.5 were chosen as the variables that
were most related with the OPLS-DA discriminant scores. The
variables that do not vary significantly are plotted in the middle
and those that changed most significantly are plotted at the top
or bottom of the S plot. The S-plots for LPS/EA vs LPS/CH,
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FIGURE 3 | Heatmap visualization for different extracts of P. multiflorum. Rows: samples; Columns: metabolites (ESI- mode).
LPS/EA vs LPS/RE, LPS/EA vs LPS/CH& LPS/RE are shown in
Figures 4B,D,F, respectively. The same process was performed
for the data from the ESI+ analysis (Supplementary Figure S4
and Table S1).
Then, compared with LPS/CH and LPS/RE groups, solo or
together, the metabolites differed significantly (P < 0.05) in the
LPS/EA group were selected as candidate biomarkers. The criteria
were restricted to features with an average normalized intensity
difference of 1.5-fold. Finally, the metabolites in the ESI+ and
ESI- mode analyses were combined and subjected to further
identification of their molecular formulas. All biomarkers were
tentatively identified with the accurate mass charge ratio by the
online METLIN database3.
Using the above mentioned approach, 412 metabolites were
identified and were selected as the biomarkers. By applying this
analysis process, the variables responsible for group separation
were selected as potential biomarker candidates. After removal of
the duplicate potential biomarkers, 21 variables were selected as
the candidates of potential biomarkers in LC/MS (Table 1).
DISCUSSION
Despite a significant increase of Heshouwu-induced
hepaototoxity has been reported, they occur in a minority
of patients in fact by means of the retrospective statistics
of medicinal liver injury cases in 302 Hospital, so that
they might be idiosyncratic liver injury based on integrated
evidence chain-based identification of Chinese herbal medicine
(Wang et al., 2015; Zhu et al., 2016). Whereas, the traditional
toxicity evaluations showed that Heshouwu treatments caused
hepatotoxicity requiring more than 50∼70 times of clinical
equivalent dose with continuous administration for 4∼8 weeks
(Wang T. et al., 2012; Li et al., 2013; Zhang et al., 2013),
resulting in difficult evaluate the hepatotoxicity of herbal
medicines. Moreover, predicting idiosyncratic hepatotoxicity
3https://metlin.scripps.edu/
reactions has been a formidable challenge. The LPS model
has been employed to evaluate IDILI successfully for several
drugs in humans, such as trovafloxacin, sulindac, halothane,
chlorpromazine, monocrotaline, ranitidine, diclofenac, and
amiodarone in toxicological experiment assessment on the basis
of the inflammatory stress hypothesis (Waring et al., 2006;
Shaw et al., 2010; Roth and Ganey, 2011; Poulsen et al., 2014).
The previous research constructed Heshouwu idiosyncratic
hepatotoxicity, based on LPS animal models, has manifested
Heshouwu could induce acute liver injury in rats cotreated
with LPS approximate to the clinical equivalent dose, and the
animal model should make it possible to assess idiosyncratic
hepatotoxicity of the herb (Li et al., 2015).
However, the idiosyncratic hepatotoxic material on the basis
of Heshouwu is still unclear. Besides, the present studies also
have controversial issue (Wang et al., 2014). Several studies
have demonstrated that anthraquinones, e.g., emodin, are the
major hepatotoxins in Heshouwu (Yu et al., 2011; Lin et al.,
2015; Ma et al., 2015). Westendorf (1993) concluded that the
herb toxicity might be associated with anthraquinones that
form highly reactive anthrones in the colon, thus resulting in
hepatotoxicity. Whereas, another report argued that the toxicity
of Heshouwu does not depend on the content of anthranoid
derivatives, on account of the stilbenes content was decreased
and emodin content was increased after being processed, it
may be correlated with the content of tetrahydroxystilbene
glucosides (Wu et al., 2012). Results showed that when free
anthraquinones (mainly emodin) are extracted with CHCl3,
comparable to the dose of which in total extracts, didn’t
induce liver damage in saline-treated rats and in LPS-treated
rats. Furthermore, solo administration of either isolated EA
extract or RE extract to normal rats failed to induce significant
liver injury (Figure 1). Meanwhile, liver damage can be
seen in a comparable dose of the EA extract and not in
RE extract in LPS-treated rats, suggesting that EA extract
was the main ingredient associated with Heshouwu induced
idiosyncratic hepatotoxicity. The mechanism of IDILI is very
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FIGURE 4 | Orthogonal partial least squares-discriminant analysis (OPLS-DA) analysis of the data generated from the ESI- mode. S-score plots
constructed from the supervised OPLS analysis of serum (B,D,F), the axes that are plotted in the S-plot from the predictive component are p1 vs. p(corr)1,
representing the magnitude and reliability, respectively. Metabolite ions with variable influence on the projection (VIP) value >1 were marked with a red square. (A,B)
Displays the result of OPLS-DA model using the data from the LPS/EA and LPS/CH groups in ESI- mode. (C,D) Displays the result of OPLS-DA modelusing the data
from the LPS/EA and LPS/RE groups in ESI- mode. (E,F) Displays the result of OPLS-DA model using the data from the LPS/EA, LPS/CH and LPS/RE groups in
ESI- mode.
complex, among which inflammation response plays a critical
role. The inflammatory stress hypothesis has provided some of
the first animal models of idiosyncratic hepatotoxicity (Roth
and Ganey, 2011; Poulsen et al., 2014). Nontoxic dose of
LPS precipitate modest inflammatory responses in mammals,
resulting in increased susceptibility to toxicity from numerous
hepatotoxic chemicals (Deng et al., 2009). These results
demonstrated that modest inflammation response, triggered
by a small dose of LPS, augments hepatotoxicity induced
by EA extract not either CH or RE extract. Furthermore,
UHPLC was used to confirm the chemical compositions of
EA extract, 91% of which was stilbenes mainly containing
2,3,5,4’-tetrahydroxy transstilbene-2-O-β-glucoside (trans-SG)
and its cis-isomer (cis-SG), the other was slight emodin-8-
O-β-D-glucopyranoside. So EA extract might be idiosyncratic
hepatotoxic constituents attributed to Heshouwu-induced IDILI.
Furthermore, our recent finding indicated that cis-SG might be
the major hepatotoxic component not either trans-SG or emodin-
8-O-β-D-glucopyranoside in LPS-treated rats. This is the first
report of idiosyncratic hepatotoxic substances in association with
Heshouwu.
Metabolomics is generally a kind of phenotype-guided study,
aiming to link phenotypic characterization of multifactorial
diseases or drug toxicity with metabolomics profiles or changes
(Ramautar et al., 2013; Frederich et al., 2016). In the present
study, we discovered that EA extract was the main component
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TABLE 1 | Identification and trends of change for potential biomarkers.
Nob R.T. (min) Biomarkers Mass Formula Content variancea
ESI+
1 0.94 L-Valine 117.0790 C5H11NO2 ↓
2 1.09 Creatine 131.0695 C4H9N3O2 ↓
3 1.09 Nicotinamide 122.0480 C6H6N2O ↑
4 3.97 epsilon-Caprolactam 113.0841 C6H11NO ↑
5 13.57 Sphingosine 299.2824 C18H37NO2 ↓
6 14.86 Orthophosphate 97.9769 H3O4P ↓
7 15.85 UDP-N-acetylmuramoyl-L-alanyl-
gamma-D-glutamyl-L-lysine
1007.2774 C34H55N7O24P2 ↑
8 19.72 Sphinganine 1-phosphate 381.2644 C18H40NO5P ↓
9 19.89 Cortol 368.2563 C21H36O5 ↓
ESI−
1 0.84 Succinate 118.0266 C4H6O4 ↑
2 0.85 D-Lombricine 270.0729 C6H15N4O6P ↓
3 0.93 Oxalosuccinate 190.0114 C6H6O7 ↑
4 0.94 Urate 168.0283 C5H4N4O3 ↑
5 0.94 gamma-Glutamyl-gamma-
aminobutyraldehyde
216.1110 C9H16N2O4 ↓
6 0.94 2-C-Methyl-D-erythritol 4-phosphate 216.0399 C5H13O7P ↓
7 0.98 O-Succinyl-L-homoserine 219.0743 C8H13NO6 ↑
8 1.11 Caproic acid 116.0837 C6H12O2 ↓
9 1.13 4-Pyridoxic acid 183.0532 C8H9NO4 ↓
10 5.38 Phenol 94.0419 C6H6O ↑
11 9.69 Imidazole lactate 156.0535 C6H8N2O3 ↓
12 19.83 beta-Nitropropanoate 119.0219 C3H5NO4 ↑
aChange trends of potential biomarkers in LPS/EA compared with LPS/CH and LPS/RE groups. bPotential biomarkers identified both in positive and negative electrospray
ionization source (ESI) mode. The levels of potential biomarkers were marked with (↓) down-regulated, (↑) up-regulated.
associated with Heshouwu-induced idiosyncratic hepatotoxic
phenotype, on the basis of the background of LPS-induced
minimal inflammation. Without the LPS-induced background,
neither EA nor the other parts of extracts displayed hepatotoxic
phenotype. Comparisons between the LPS/EA vs. EA group
and LPS vs EA group might be meaningful in explanation
of the systematic perturbation of LPS or EA, but we did not
focus on these issues. Thus, we emphasized the comparisons
between EA/LPS group and the other extracts/LPS groups to find
potential metabolomic biomarkers associated with idiosyncratic
hepatotoxicity. Reports have shown that metabolomic approach
based on the UHPLC-MS can be used as a robust tool to inspect
the effects of hepatotoxic compounds (Weiss and Kim, 2011;
Xue et al., 2014; Rofiee et al., 2015). Accordingly, UHPLC-MS
based metabolomic technique was utilized used to investigate the
alterations of plasma metabolite profiles in rats after combined
exposure to LPS and with different extracts of Heshouwu. The
data were analyzed by PCA showing an obvious separation
among the samples. Especially, LPS/EA group was far away
from the remaining four groups, suggesting EA-induced liver
injury may be significantly different from others. The results
revealed that this metabolomics can be utilized to characterize
the metabolic perturbation of different extracts of Heshouwu
to elucidate the toxic effects. Biomarkers, serving as early
biochemical changes in drug induced hepatotoxicity, provided
an opportunity to develop predictive biomarkers that could
provide valuable insights about mechanisms of hepatotoxicity
(Miao et al., 2016). Compared with LPS/CH and LPS/RE treated
groups, 21 potential biomarkers related to liver injury, such
as oxalosuccinate, succinate, creatine, and L-valine acid and so
on, had been differentially expressed in LPS/EA group. The
important plasma biomarkers related to liver injury were further
analyzed and the possible metabolic pathway of EA-induced
hepatotoxicity is displayed in Figure 5.
As shown in Figure 5, Supplementary Figure S5, and
Supplementary Table S2 changes in tricarboxylic acid cycle (TCA
cycle) and sphingolipid metabolism were prominent among the
affected metabolisms in the LPS/EA group compared to LPS/CH
and LPS/RE group.; nine out of 21 significant metabolites
accountable for class discrimination were oxalosuccinate,
succinate, Urate, 4-pyridoxic acid, sphinganine 1-phosphate,
nicotinamide, sphingosine, L-valine, and creatine by schematic
diagram of the disturbed metabolic pathway. In addition, the
relative mean peak area of nine different metabolites was graphed
in Supplementary Figure S6. The relative concentration of nine
endogenous metabolites was significantly affected for LPS/EA
treatment. By contrast, there was not significant change whether
in normal group or in LPS group, LPS/CH group and LPS/RE
group. They could be considered as potential markers for
biological pathway analysis. Previous studies showed that one of
the reasons for drug induced liver injury is the disturbance of the
hepatocyte energy metabolism, particularly in the Krebs cycle
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FIGURE 5 | Schematic diagram of the disturbed metabolic pathway related to LPS/EA treatment. The notations are as follows: (↑) in red, metabolite higher
in LPS/EA treated group than in LPS/CH and LPS/RE groups; (↓) in green, metabolite lower in LPS/EA treated group than in PS/CH and LPS/RE groups. The related
metabolic pathways are cycled in a black box; ALT, glutamate pyruvate transaminase; AST, aspartate aminotransferase.
(Mogilevskaya et al., 2006). In the experiment, TCA cycle may be
most related to the hepatotoxicity of EA. The observed significant
increase in the level of succinate and oxalosuccinate in LPS/EA
treated rats revealed that dysfunction of energy metabolism and
EA influenced the activity of mitochondrial enzymes related to
the TCA cycle, leading to the disruption of energy metabolism
in the liver (Figure 5). Succinate and oxalosuccinic are the
intermediates in the TCA process, which are mainly dealt with
in liver mitochondria. Furthermore, TCA cycle function also can
be viewed as a bridge connected with other disturbed metabolic
pathways. For example, succinate is an intermediate in TCA
cycle, at the same time it is the metabolite of 4-Pyridoxate (Also
in vitamin B6 metabolism pathway). Therefore, it was possible
that EA affected the energy metabolism in liver mitochondria.
Additionally, decreased plasma creatine levels were seen from
LPS/EA treated rats. Metabolomic analysis also showed lower
levels of creatine in subjects with steatosis (Kalhan et al., 2011).
Creatine, found to be decreased in both the animal and human
non-alcoholic fatty liver disease samples, has long been employed
to evaluate possible liver dysfunction (Barr et al., 2010). The
creatine-phosphocreatine system is essential for cellular energy
transportation (Sun et al., 2012). Therefore, the decreased levels
of serum creatine observed in the LPS/EA treated rats are
consistent with disruption of the energy homeostasis.
In sphingolipids metabolism, sphingolipids play significant
roles in membrane biology and provide many bioactive
metabolites, such as ceramide, sphinganine, sphingosine,
sphingosine 1-phosphate(S1P), that regulate cell function as
intracellular and extracellular mediators (Gault et al., 2010;
Nojima et al., 2015). As a sphingolipid metabolite, ceramide
is metabolized to sphingosine and S1P by ceramidase and
sphingosine kinases (Nixon, 2009). Sphinganine 1-phosphate
(sphinganine 1-P) is structurally similar to S1P and is produced
by the ATP-dependent phosphorylation of sphinganine by
sphingosine kinase (Le Stunff et al., 2004). In this study, the
decreased concentration of sphingosine and sphinganine 1-P
in the LPS/EA group compared with LPS/CH and LPS/RE
groups were observed. The concentration of sphingosine
decreased in LPS/EA treated rats might be associated with
ceramide accumulation that has also been demonstrated in
models of hepatic I/R injury and liver transplantation in vivo
(Bradham et al., 1997; Alessenko et al., 2002). In addition, plasma
sphinganine 1-P levels were noted to be decreased after hepatic
I/R injury and it has been reported to protect against both liver
and kidney injury (Park et al., 2010).
Taken together, associated with the aforementioned
inflammatory response activation involved in the pathogenesis
of liver injury, interactions between the inflammatory response
and metabolic systems might play a key role in the biological
mechanism of EA extract induced idiosyncratic hepatotoxicity.
However, some limitations still exist in this investigation.
Despite the potential biomarkers of the idiosyncratic hepatotoxic
mechanism of EA extract distinguished with other two extracts
have been explored, but verification of these biomarkers and
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systematic clinical elucidation and evidence are still needed.
Additionally, the material basis and exact biological mechanism
responsible for the IDILI are also needed further exploration.
CONCLUSION
Biochemistry and histopathology analyses indicated that EA
extract might be the major hepatotoxic constituents of Heshouwu
in LPS-treated rats, compared to CH and RE extracts. The
comprehensive metabolomics approach based on UHPLC-MS
was developed and successfully applied to explore the biological
changes induced by different extracts of Heshouwu in LPS-
treated rats. By virtue of the information extracted from the
multivariate analysis, specific changes of metabolites among
different extracts of Heshouwu were identified, and 21 key
biomarkers which are responsible for the hepatotoxic compounds
were discovered. Alterations in these metabolites primarily
involved TCA cycle and sphingolipid metabolism pathways.
This research not only provide systematic experimental basis
for the major hepatotoxic constituents of Heshouwu firstly,
but exemplifies that metabolomics could provide a promising
way to elucidate hepatotoxic mechanisms of Heshouwu, thereby
permitting a comprehensive understanding of systemic toxicity
for traditional Chinese medicine.
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